Amphastar Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $742.0M
Liabilities Breakdown FY2022
Total Liabilities: $213.3M
Asset Breakdown
Total Assets: $742.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $156.1M | 21.0% |
| Accounts Receivable | $88.8M | 12.0% |
| Inventory | $103.6M | 14.0% |
| Property, Plant & Equipment | $238.3M | 32.1% |
| Goodwill | $3.1M | 0.4% |
| Intangible Assets | $4.9M | 0.7% |
| Other Assets | $147.2M | 19.8% |
Liabilities Breakdown
Total Liabilities: $213.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $20.5M | 9.6% |
| Long-Term Debt | $76.6M | 35.9% |
| Other Liabilities | $116.2M | 54.5% |